ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005

Rauscher Decision Put Off To July 1: Administration Backs Pay Raise Bill

June 25, 1976

Funding Opportunities: ONS Invites Applications For Instrumentation Grants on Fatigue

January 24, 1997

NCI Resources, Services Available For Cancer Research

June 7, 1996

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

December 26, 2003

New Drug Reduces Nausea and Vomiting

October 31, 2003